The Role of Pharmacogenomics in Management of HIV Infection- Spooner

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/37

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:18 AM on 6/7/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

38 Terms

1
New cards

What are important counseling points for ART?

Strict adherence to medication dosing and office visits, encouraging consistent use of 1 pharmacy, performing a profile review at initiation and every refill, ensure Pt is comfortable with disclosing OTC rxs

2
New cards

what medication do we used for pediatric patients weighing under 40kg

efavirenz

3
New cards

What is considered a high viral loa

>100,000 copies/mL

4
New cards

What is first line treatment for HIV?

INSTI + 2 NRTIs

5
New cards

What products contain abacavir?

Ziagen, Epzicom, Trizivir, Triumeq

6
New cards

what are the two roles of genomic information in ART

identifying ARV resistance mutation, identify host cell genome variants that modulate response and adverse effects (not done very frequently)

7
New cards

what kind of ART is abacavir

NRTI

8
New cards

abacavir clinical pearls

increased risk of MI

no renal dose adjustment

hypersensitivity reaction

9
New cards

when do hypersensitivty reactions occur with abacavir

within the first 6 weeks of treatment if genetic prescreening is not performed

10
New cards

what symptoms appear with hypersensivity reaction (at least 2)

fever, rash, N/V/ abdominal pain, fatigue, cough, dyspnea

11
New cards

what do you need to immediately do if a patient has a hypersensitive reaction

immediately discontinue and never rechallenge, can lead to life threatening reactiong

12
New cards

what patient populations have HLA-B*57:01 allele

european, african, asian (japenese does not have any)

13
New cards

Which regimens are not recommended for rapid ART initiation?

Which regimens are not recommended for rapid ART initiation?

14
New cards

in treatment naive individuals when do you need to screen patients

prior to initiating therapy or prior to considering abacavir treatment

15
New cards

true or false HLA-B*57:01 status has no effects on drugs PK/PD

true

16
New cards

if you are HLA-B*57:01 positive

do not initiate abacavir because of increased risk of reactions, mark in allergy section, use alternative NRTI

17
New cards

if you are HLA-B*57:01 negative

may start abacavir, provide counseling and education for reactions

18
New cards

true or false we do patch testing for HLA-B* 57:01

false

19
New cards

what kind of ART is efavirenz

NNRTI

20
New cards

adverse effects of efavirenz

disordered sleep, horrible dreams, psychosis, depression, suicidal ideation, occurs in first few days- 6 weeks abused in south africa for these effects

21
New cards

why was efavirenz removed from the "use in most situations" list

due to neurologic adverse effects/ discontinuation/ and drug interactions

22
New cards

what is efavirenz metabolized by

CYP2B6, autoinducer with chronic dosing it enhances its own metabolism

23
New cards

what can you use with efavirenz that you can not use with other ART

rifampin

24
New cards

what population is efavirenz recommended for

pregnant women and women who wish to become pregnant

25
New cards

CYP2B6 poor metabolizer phenotype

reduced clearance of efavirenz, increased toxicity, increased risk of discontinuation

26
New cards

What are the dosing recommendations of efavirenz for ultra-rapid, rapid, and normal metabolizers of CYP2B6?

600mg/ day

27
New cards

What are the dosing recommendations of efavirenz for poor metabolizers of CYP2B6?

400 or 200mg/ day

28
New cards

What are the dosing recommendations of efavirenz for intermediate metabolizers of CYP2B6?

400mg/ day

29
New cards

symfi-lo contains

efavirenz with TDF/ lamivudine

30
New cards

what are the disadvantages of precision dose reduction with efavirenz

genotyping required, multiple copays, potential for sub-therapeutic EFV concentration and virologic failure, drug interactions

31
New cards

what kind of drug is atazanavir

protease inhibitor

32
New cards

atazanavir as a single agent

reyataz

33
New cards

atazanavir with COBI

evotaz

34
New cards

what does atazanavir require for doing

boosting with RTV or COBI

35
New cards

what is the adverse effect of atazanavir

indirect hyperbilirubinemia from inhibition of UGT1A1 mediated glucuronidation of bilirubin which increases plasma concentration of indirect bilirubin

36
New cards

who is at highest risk for bilirubin related discontinuation

patients who carry 2 UGT1A1 decreased function alleles

37
New cards

extensive metabolizer or intermediate metabolizer of UGT1A1

can use atazanavir

38
New cards

poor metabolizer of UGT1A1

high risk of bilirubin related discontinuation do not use atazanavir